0001416377-19-000002.txt : 20190212 0001416377-19-000002.hdr.sgml : 20190212 20190212161433 ACCESSION NUMBER: 0001416377-19-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190212 DATE AS OF CHANGE: 20190212 EFFECTIVENESS DATE: 20190212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Viracta Therapeutics, INC. CENTRAL INDEX KEY: 0001416377 IRS NUMBER: 260814473 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-327918 FILM NUMBER: 19590938 BUSINESS ADDRESS: STREET 1: 4747 EXECUTIVE DRIVE STREET 2: SUITE 700 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584008470 MAIL ADDRESS: STREET 1: 4747 EXECUTIVE DRIVE STREET 2: SUITE 700 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: HEMAQUEST PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20120321 FORMER COMPANY: FORMER CONFORMED NAME: HEMAQUEST PHARMACEUTICALS DATE OF NAME CHANGE: 20090108 FORMER COMPANY: FORMER CONFORMED NAME: HemaGenex Pharmaceuticals Inc DATE OF NAME CHANGE: 20071026 D/A 1 primary_doc.xml X0708 D/A LIVE 0001416377 Viracta Therapeutics, INC. 2533 S. Coast Highway 101, Suite 210 Cardiff CA CALIFORNIA 92007 858-771-4190 DELAWARE HEMAQUEST PHARMACEUTICALS, INC. HEMAQUEST PHARMACEUTICALS HemaGenex Pharmaceuticals Inc Corporation true David Slack c/o Viracta Therapeutics, Inc. 2533 S. Coast Highway 101, Suite 210 Cardiff CA CALIFORNIA 92007 Executive Officer Ivor Royston c/o Viracta Therapeutics, Inc. 2533 S. Coast Highway 101, Suite 210 Cardiff CA CALIFORNIA 92007 Executive Officer Director Richard Ghalie c/o Viracta Therapeutics, Inc. 2533 S. Coast Highway 101, Suite 210 Cardiff CA CALIFORNIA 92007 Director James Woody c/o Viracta Therapeutics, Inc. 2533 S. Coast Highway 101, Suite 210 Cardiff CA CALIFORNIA 92007 Director Patrick Soon-Shiong c/o Viracta Therapeutics, Inc. 2533 S. Coast Highway 101, Suite 210 Cardiff CA CALIFORNIA 92007 Director Standish Fleming c/o Viracta Therapeutics, Inc. 2533 S. Coast Highway 101, Suite 210 Cardiff CA CALIFORNIA 92007 Director Barry Simon c/o Viracta Therapeutics, Inc. 2533 S. Coast Highway 101, Suite 210 Cardiff CA CALIFORNIA 92007 Director Biotechnology Decline to Disclose 06b true 0001607677-18-000004 2018-11-30 false true false 0 10695495 10695495 0 Total Amount Sold includes $10,000,000.08 of new cash and $695,494.65 of cancellation of indebtedness false 6 0 0 0 false Viracta Therapeutics, INC. /s/ Ivor Royston Ivor Royston Chief Executive Officer 2019-02-12